Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma

Clinical trial NCT03291314 · COMPLETED

Trial details

NCT number: NCT03291314
Sponsor: Universitair Ziekenhuis Brussel
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma (WHO-Grade IV Glioma)

Start date: 2017-05-03
Primary completion: 2019-01-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.